Adherium Limited (ASX: ADR)
Health Care · Health Care Technology · AU
AU$0.08
+2.67% today · -84.6% 1Y
Adherium Limited (ASX: ADR) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $2.95M and employs 40 people.
Over the last twelve months the share price has lost 84.6%, trading between 0.08 and 0.80.
Tweenvest scores Adherium Limited across four factors: quality 16/100, value 48/100, growth 80/100. Its strongest factor is growth.
ADR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.95M
- Revenue (TTM)
- $1.45M
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- 1.12
- 52-week high
- AU$0.80
- 52-week low
- AU$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 54.89M
- Employees
- 40
- Next earnings
- —
About Adherium Limited
Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia. A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.
- ISIN
- AU000000ADR1
- Founded
- 2001
- Listed since
- Aug 26, 2015
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Diagnamed Holdings Corp.CNSX: DMED | $3.69M | CA$0.04 | -11.11% |
| Feedback plcAIM: FDBK | $3.68M | £0.07 | +3.94% |
| Monsenso A/SCPSE: MONSO | $3.59M | Dkr0.25 | 0.00% |
| StrainsforPains, Inc.OTCPK: EBYH | $2.99M | $0.23 | +15.57% |
| Pangenomic Health Inc.CNSX: NARA | $2.88M | CA$0.16 | -46.67% |
| Imaging Biometrics Ltd.LSE: IBAI | $2.86M | £0.01 | -12.50% |
| iSpecimen Inc.NasdaqCM: ISPC | $2.85M | $1.13 | +4.63% |
| Global Health LimitedASX: GLH | $2.42M | AU$0.06 | -3.28% |
Figures last refreshed Oct 11, 2026.